These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30134158)

  • 41. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
    Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits.
    Yang YR; McCoy LE; van Gils MJ; Andrabi R; Turner HL; Yuan M; Cottrell CA; Ozorowski G; Voss J; Pauthner M; Polveroni TM; Messmer T; Wilson IA; Sanders RW; Burton DR; Ward AB
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
    Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
    J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer.
    Cao L; Pauthner M; Andrabi R; Rantalainen K; Berndsen Z; Diedrich JK; Menis S; Sok D; Bastidas R; Park SR; Delahunty CM; He L; Guenaga J; Wyatt RT; Schief WR; Ward AB; Yates JR; Burton DR; Paulson JC
    Nat Commun; 2018 Sep; 9(1):3693. PubMed ID: 30209313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens.
    Whitaker N; Hickey JM; Kaur K; Xiong J; Sawant N; Cupo A; Lee WH; Ozorowski G; Medina-Ramírez M; Ward AB; Sanders RW; Moore JP; Joshi SB; Volkin DB; Dey AK
    J Pharm Sci; 2019 Jul; 108(7):2264-2277. PubMed ID: 30776383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.
    Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ
    J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.
    Gulla K; Cibelli N; Cooper JW; Fuller HC; Schneiderman Z; Witter S; Zhang Y; Changela A; Geng H; Hatcher C; Narpala S; Tsybovsky Y; Zhang B; Vrc Production Program ; McDermott AB; Kwong PD; Gowetski DB
    Vaccine; 2021 Jun; 39(25):3379-3387. PubMed ID: 34020817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein.
    Behrens AJ; Vasiljevic S; Pritchard LK; Harvey DJ; Andev RS; Krumm SA; Struwe WB; Cupo A; Kumar A; Zitzmann N; Seabright GE; Kramer HB; Spencer DI; Royle L; Lee JH; Klasse PJ; Burton DR; Wilson IA; Ward AB; Sanders RW; Moore JP; Doores KJ; Crispin M
    Cell Rep; 2016 Mar; 14(11):2695-706. PubMed ID: 26972002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer.
    Behrens AJ; Harvey DJ; Milne E; Cupo A; Kumar A; Zitzmann N; Struwe WB; Moore JP; Crispin M
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
    Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW
    J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.
    Wang Q; Zhang S; Nguyen HT; Sodroski J
    J Virol; 2024 Feb; 98(2):e0159423. PubMed ID: 38289101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin.
    Ringe RP; Cruz Portillo VM; Dosenovic P; Ketas TJ; Ozorowski G; Nogal B; Perez L; LaBranche CC; Lim J; Francomano E; Wilson IA; Sanders RW; Ward AB; Montefiori DC; Nussenzweig MC; Klasse PJ; Cupo A; Moore JP
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.
    Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK
    J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS.
    AlSalmi W; Mahalingam M; Ananthaswamy N; Hamlin C; Flores D; Gao G; Rao VB
    J Biol Chem; 2015 Aug; 290(32):19780-95. PubMed ID: 26088135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers.
    Guenaga J; Dubrovskaya V; de Val N; Sharma SK; Carrette B; Ward AB; Wyatt RT
    J Virol; 2015 Dec; 90(6):2806-17. PubMed ID: 26719252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
    Klasse PJ; Ketas TJ; Cottrell CA; Ozorowski G; Debnath G; Camara D; Francomano E; Pugach P; Ringe RP; LaBranche CC; van Gils MJ; Bricault CA; Barouch DH; Crotty S; Silvestri G; Kasturi S; Pulendran B; Wilson IA; Montefiori DC; Sanders RW; Ward AB; Moore JP
    PLoS Pathog; 2018 Feb; 14(2):e1006913. PubMed ID: 29474444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.
    Kumar S; Lin X; Ngo T; Shapero B; Sou C; Allen JD; Copps J; Zhang L; Ozorowski G; He L; Crispin M; Ward AB; Wilson IA; Zhu J
    mBio; 2021 Jun; 12(3):e0042921. PubMed ID: 34156262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers.
    de Taeye SW; Go EP; Sliepen K; de la Peña AT; Badal K; Medina-Ramírez M; Lee WH; Desaire H; Wilson IA; Moore JP; Ward AB; Sanders RW
    J Biol Chem; 2019 Apr; 294(14):5616-5631. PubMed ID: 30728245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.